| | | Geschrieben am 30-04-2012 EANS-Adhoc: LifeWatch AG publishes Annual Report 2011
 | 
 
 --------------------------------------------------------------------------------
 ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
 distribution. The issuer is solely responsible for the content of this
 announcement.
 --------------------------------------------------------------------------------
 
 annual report/LifeWatch AG
 
 30.04.2012
 
 Neuhausen am Rheinfall/Switzerland - LifeWatch AG (SIX Swiss
 Exchange: LIFE)today published its Annual Report 2011 including
 results for the financial year 2011 as presented on February 29,
 2012. The LifeWatch Annual Report 2011 is available in the Investor
 Relations section of the LifeWatch website www.irlifewatch.com and
 can be downloaded via this link
 http://www.irlifewatch.com/lifewatch/financial-publications/. You can
 order copies via lifewatch@sensus.ch.
 
 About LifeWatch AG:
 
 LifeWatch AG, headquartered in Neuhausen am Rheinfall, Switzerland
 and listed on SIX Swiss Exchange (LIFE), is the leading healthcare
 technology and solutions company, specializing in advanced
 telemedicine systems and wireless remote patient monitoring services.
 LifeWatch provides services to high-risk and chronically ill
 patients, health conscious consumers and wellness programs. LifeWatch
 has subsidiaries in the United States, the Netherlands, Japan, the
 United Kingdom, Switzerland and Israel. LifeWatch AG is the parent
 company of LifeWatch Services, Inc., a leading US-based wireless
 remote telemedicine provider. LifeWatch services include Home Sleep
 Testing for Obstructive Sleep Apnea patients under the brand name
 NiteWatch. For additional information, please visit www.lifewatch.com
 and www.nitewatchservices.com.
 
 Sign-up for customized e-mail alerts and documentation requests is
 available at http://production.investis.com/lifewatch/alert-service/
 
 This press release includes forward-looking statements. All
 statements other than statements of historical facts contained in
 this press release, including statements regarding future results of
 operations and financial position, business strategy and plans and
 objectives for future operations, are forward-looking statements. The
 words "believe," "may," "will," "estimate," "continue,""anticipate,"
 "intend," "expect" and similar expressions are intended to identify
 forward-looking statements. LifeWatch AG has based these forward
 looking statements largely on current expectations and projections
 about future events and financial trends that it believes may affect
 the financial condition, results of operations, business strategy,
 short term and long term business operations and objectives, and
 financial needs. These forward-looking statements are subject to a
 number of risks, uncertainties and assumptions. In light of these
 risks, uncertainties and assumptions, the forward-looking events and
 circumstances described may not occur and actual results could differ
 materially and adversely from those anticipated or implied in the
 forward-looking statements. All forward-looking statements are based
 only on data available to LifeWatch AG at the time of the issue of
 this press release. LifeWatch AG does not undertake any obligation to
 update any forward-looking statements contained in this press release
 as a result of new information, future events or otherwise.
 
 THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
 AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
 PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
 PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
 AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
 INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
 AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
 SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
 REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
 OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
 PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
 REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
 PUBLIC OFFERING OF  ECURITIES TO BE MADE IN THE UNITED STATES WILL BE
 MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
 OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
 INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
 STATEMENTS OF THE ISSUER.
 
 Further inquiry note:
 Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG:
 Tel       +41 52 632 00 50 | Fax   +41 52 632 00 51;
 Email:   kobibe@lifewatch.com
 
 Sensus Investor and Public Relations GmbH, Zürich:
 Tel       +41 43 366 55 11 | Fax   +41 43 366 55 12
 Email:   lifewatch@sensus.ch
 
 end of announcement                               euro adhoc
 --------------------------------------------------------------------------------
 
 issuer:      LifeWatch AG
 Rundbuckstrasse 6
 CH-8212 Neuhausen am Rheinfall
 phone:       +41 52 632 00 50
 FAX:         +41 52 632 00 51
 mail:        users@lifewatch.com
 WWW:         www.lifewatch.com
 sector:      Healthcare Providers
 ISIN:        CH0012815459
 indexes:     SPI, SPIEX
 stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard:
 SIX Swiss Exchange
 language:   English
 
 Kontaktinformationen:
 
 Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
 Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.
 
 Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
 Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.
 
 Sie suche nach weiteren Pressenachrichten?
 Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.
 
 http://www.bankkaufmann.com/topics.html
 
 Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.
 
 @-symbol Internet Media UG (haftungsbeschränkt)
 Schulstr. 18
 D-91245 Simmelsdorf
 
 E-Mail: media(at)at-symbol.de
 
 392716
 
 weitere Artikel:
 
 | 
EANS-Adhoc: Die Value Management & Research AG weist einen Jahresfehlbetrag in
Höhe von 545 TEUR für das Geschäftsjahr 2011 aus -------------------------------------------------------------------------------- 
  Ad-hoc-Meldung nach § 15 WpHG übermittelt durch euro adhoc mit dem Ziel 
  einer europaweiten Verbreitung. Für den Inhalt ist der Emittent 
  verantwortlich. 
-------------------------------------------------------------------------------- 
 
30.04.2012 
 
Kronberg, 30.04.2012 - Die Value Management & Research AG, Kronberg,  
gibt folgende aufgestellte Ergebniszahlen für das Geschäftsjahr 2011  
bekannt. Alle Zahlen entstammen dem IFRS-Abschluss der Gruppe. 
 
Zum mehr...
 
EANS-Tip Announcement: Sanacorp Pharmaholding AG / Announcement according to
Articles 37v, 37w, 37x et seqq. of the WpHG (the German Securities Act) with the
objective of Europe-wide distribution -------------------------------------------------------------------------------- 
  Tip announcement for financial statements transmitted by euro adhoc. The 
  issuer is responsible for the content of this announcement. 
-------------------------------------------------------------------------------- 
 
The company  Sanacorp Pharmaholding AG is declaring its financial reporting 
publication plan below: 
 
Report Type: Quarterly Report Within The First Half Of The Year 
German: 
Publication Date    : 14.05.2012 
Publication Location: http://pdf.sanacorp.de/_pdf/2012_qb_ag_de_1.pdf mehr...
 
EANS-Hinweisbekanntmachung: Sanacorp Pharmaholding AG / Bekanntmachung gemäß §
37v, 37w, 37x ff. WpHG mit dem Ziel der europaweiten Verbreitung -------------------------------------------------------------------------------- 
  Hinweisbekanntmachung für Finanzberichte übermittelt durch euro adhoc mit 
  dem Ziel einer europaweiten Verbreitung. Für den Inhalt ist der Emittent 
  verantwortlich. 
-------------------------------------------------------------------------------- 
 
Hiermit gibt die Sanacorp Pharmaholding AG bekannt, dass folgende Finanzberichte 
veröffentlicht werden: 
 
Bericht: Quartalsfinanzbericht innerhalb des 1. Halbjahres 
Deutsch: 
Veröffentlichungsdatum: 14.05.2012 mehr...
 
Innovations in Dairy: 10-12 July 2012 - Radisson Blu Hotel, Amsterdam London (ots/PRNewswire) - 
 
   http://www.fi-dairyinnovation.com   
 
   Today's consumer expects a lot from dairy products. They want 
innovative products that give them added value, from indulgent 
flavours to nutritional and functional health benefits. However 
developing these products presents huge challenges to the dairy 
industry from overcoming the technical difficulties in taste, texture 
and shelf life to having to adhere to strict regulatory guidelines. 
 
   With the global dairy market forecast to reach EUR5bn by 2015*, 
food and mehr...
 
EANS-Total Voting Rights: Atrium European Real Estate Limited / Release
according to article 93 BörseG with the aim of a Europe-wide distribution -------------------------------------------------------------------------------- 
  Total number of voting rights announcement transmitted by euro adhoc. The 
  issuer is responsible for the content of this announcement. 
-------------------------------------------------------------------------------- 
 
Atrium European Real Estate Limited hereby announces that at the end  
of the month April 2012 the number of voting rights amounts to a  
total of 372,980,527 voting rights. The change of total voting rights 
is effective as of 05.04.2012. 
 
additional mehr...
 
 | 
 | 
 | Mehr zu dem Thema Finanzen Der meistgelesene Artikel zu dem Thema:
 
 Century Casinos wurde in Russell 2000 Index aufgenommen
 durchschnittliche Punktzahl: 0
 Stimmen: 0
 
 
 
 |